Illinois · Nonprofit
STL CURE SARCOMA
STL CURE SARCOMA (Illinois) receives grants from 1 organization whose IRS filings report $50 to it, the largest being EDWARD JONES FOUNDATION ($50). 0 of them have funded it in more than one year.
Against its field
STL CURE SARCOMA runs a healthier operating margin than three-quarters of the 6,881 health nonprofits its size.
this organization peer median middle 50% of peers· 6,881 health nonprofits $100k–$1M, FY2025
Three funders worth looking at
Grantmakers with no record of funding this organization, ranked by how strongly the co-funder graph and the mission embeddings agree. The evidence is in section 03.
- Ivah and Jesse Pistono Charitable and Scholarship Trustlocal
- The St Louis Men's Group Against Cancerportfolio match
- United Way of South Central Illinoislocal
The organization over time
Each line starts at 100 in 2023, so what you read is the shape rather than the size: 150 means half as much again as 2023, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
78% of STL CURE SARCOMA’s revenue is contributions — about as donation-reliant as the typical peer (83% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 3 reported years ran a deficit.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
From the IRS filings of STL CURE SARCOMA’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
STL CURE SARCOMA draws 100% of its grant income from funders outside Illinois, across 1 state in all.
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Funders to approach
Grantmakers that don’t fund you yet, surfaced two ways: they back organizations that share your funders, or their grantees resemble your mission. The ones both signals agree on come first.
- Ivah and Jesse Pistono Charitable and Scholarship TrustlocalMO · funds 2 organizations near you
- The St Louis Men's Group Against Cancerportfolio matchits grantees resemble your mission
- United Way of South Central IllinoislocalIL · funds 2 organizations near you
- Mercy Hospitals East Communitiesportfolio matchits grantees resemble your mission
- Young Texans Against Cancerportfolio matchits grantees resemble your mission
- Mercy Hospital Southportfolio matchits grantees resemble your mission
- Ssm Health Care Corporationportfolio matchits grantees resemble your mission
- Ambers Antibodies Incportfolio matchits grantees resemble your mission
- The David and Barbara Mungenast Foundation Incportfolio matchits grantees resemble your mission
- Haymakers for Hope Incportfolio matchits grantees resemble your mission
- Gail L Baird Foundation Incportfolio matchits grantees resemble your mission
- John Albuerne Family Foundation Inc co Steven P Block Directorportfolio matchits grantees resemble your mission
From the co-funder graph (funders backing at least two comparable organizations, shrunk for grantee count, donor-advised and mega-funds excluded) and the universe embeddings. A research starting point; overlap is association, not a guarantee of fit.
Organizations like STL CURE SARCOMA
Nonprofits whose mission and program text most resemble this one, by semantic similarity over the universe of US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Illinois
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Screen this organization
A dated, signed PDF of the compliance screen for STL CURE SARCOMA: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds STL CURE SARCOMA?
- STL CURE SARCOMA (Illinois) receives grants from 1 organization whose IRS filings report $50 to it, the largest being EDWARD JONES FOUNDATION ($50). 0 of them have funded it in more than one year.
- How many funders does STL CURE SARCOMA have?
- IRS filings report 1 organization giving $50 in grants to STL CURE SARCOMA.
- Who is the largest funder of STL CURE SARCOMA?
- EDWARD JONES FOUNDATION is the largest funder on record, with $50 in grants. The full list of funders is on this page.
- How can an organization like STL CURE SARCOMA find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Illinois. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2023–2025), and the filings of 1funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported August 27, 2026. What this page cannot tell you · view filing